Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV
about
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism.Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1.Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature.Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events.Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report
P2860
Q42349373-FD107668-3083-4BFF-941F-D7C583449449Q47642315-65BB8A10-F542-4828-A35B-ED579E59F8E5Q47657221-41637972-ED1C-4431-98D9-A739E7A18B84Q50045992-B603908A-3177-4F16-B4DA-9BB03E5CAEFEQ53694789-9E993E18-2D8F-418C-BE61-CF8EB9E3C1B2Q54254997-77F855ED-3281-472F-9E47-EDF9DE8640F4Q56524474-8515CF64-E039-4191-8246-46089440178B
P2860
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Real-World Experiences with th ...... rferon plus Ribavirin with HCV
@en
type
label
Real-World Experiences with th ...... rferon plus Ribavirin with HCV
@en
prefLabel
Real-World Experiences with th ...... rferon plus Ribavirin with HCV
@en
P2093
P2860
P356
P1476
Real-World Experiences with th ...... rin with HCV NS3/4A Inhibitors
@en
P2093
Akinobu Tawada
Eiichiro Suzuki
Fumio Imazeki
Hitoshi Maruyama
Koji Takahashi
Makoto Arai
Masato Nakamura
Osamu Yokosuka
Reina Sasaki
Sadahisa Ogasawara
P2860
P356
10.3390/IJMS18050906
P407
P50
P577
2017-04-25T00:00:00Z